|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2004-1-30
|
|
pubmed:abstractText |
The nonsystemic steroid budesonide has been used to treat active ileocecal and ileocolonic Crohn's disease (CD). This study investigated the optimal budesonide dose using a pH-dependent release formulation. The goal of treatment was the remission of CD (CDAI <150) within 6 weeks of treatment.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0179-1958
|
|
pubmed:author |
pubmed-author:AdlerGG,
pubmed-author:AndusTT,
pubmed-author:CaesarII,
pubmed-author:German/Austrian Budesonide Study Group,
pubmed-author:GierendMM,
pubmed-author:GroteGG,
pubmed-author:HerfarthHH,
pubmed-author:MalchowHH,
pubmed-author:PetriAA,
pubmed-author:SchölmerichJJ,
pubmed-author:VogelsangHH
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
19
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
147-52
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:13680283-Adult,
pubmed-meshheading:13680283-Anti-Inflammatory Agents,
pubmed-meshheading:13680283-Budesonide,
pubmed-meshheading:13680283-Colonic Diseases,
pubmed-meshheading:13680283-Crohn Disease,
pubmed-meshheading:13680283-Dose-Response Relationship, Drug,
pubmed-meshheading:13680283-Double-Blind Method,
pubmed-meshheading:13680283-Drug Administration Schedule,
pubmed-meshheading:13680283-Female,
pubmed-meshheading:13680283-Humans,
pubmed-meshheading:13680283-Hydrocortisone,
pubmed-meshheading:13680283-Ileal Diseases,
pubmed-meshheading:13680283-Male,
pubmed-meshheading:13680283-Treatment Outcome
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Analysis of the therapeutic efficacy of different doses of budesonide in patients with active Crohn's ileocolitis depending on disease activity and localization.
|
|
pubmed:affiliation |
Department of Internal Medicine, University of Regensburg, 93042 Regensburg, Germany. hans.herfarth@klinik.uni-regensburg.de
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|
